What happens when the insurer can say no? Assessing prior authorization as a tool to prevent high-risk prescriptions and to lower costs

Robust Nonparametric Confidence Intervals for Regression-Discontinuity Designs

Sebastián Calónico, Matias D. Cattaneo, Rocío Titiunik · Econometrica · 2014 · 3K citations · Full text

Public Health, Biostatistics, Causal Inference +16

Identification and Estimation of Treatment Effects with a Regression-Discontinuity Design

Jinyong Hahn, Petra Todd, Wilbert van der Klaauw · Econometrica · 2001 · 2.8K citations

Public Health, Economics, Causal Inference +12

Optimal Bandwidth Choice for the Regression Discontinuity Estimator

Guido W. Imbens, Kaushik Kalyanaraman · The Review of Economic Studies · 2011 · 2.2K citations · Full text

Natural Sciences, Data Science, Econometrics +14

Health insurance and the demand for medical care: evidence from a randomized experiment.

Willard G. Manning, Joseph P. Newhouse, Naihua Duan et al. · PubMed · 1987 · 2.1K citations

Public Affairs, Economics, Insurance +17

Vital Signs: Overdoses of Prescription Opioid Pain Relievers - United States, 1999-2008

Leonard J. Paulozzi, Christopher M. Jones, Karin A. Mack et al. · Journal of Bioresource Management · 2011 · 1.3K citations

Nursing, Clinical Toxicology, Pharmacology +16